Before wound debridement, immunoglobulin (TIG) directly into the wound and IM
Dose: 3000-6000 units IM with adequate mL to wound
Does not reverse toxin already bound to CNS. Binds circulating toxin<unk>  toxoid; patients do NOT develop immunity after<unk>  infection
Dose: 3000-6000 units IM with adequate mL to wound
Does not reverse toxin already bound to CNS. Binds circulating toxin
Place patient in a quiet room
Provide sedation with Benzodiazepines or phenobarbital
Airway management via intubation or tracheostomy should be performed when patient exhibits dysphagia or respiratory difficulties
Autonomic dysfunction management with magnesium sulfate or labetalol, morphine and clonidine
Magnesium sulfate has several desirable attributes for control of spasticity and autonomic dysfunction in<unk> 
Acts as a presynaptic neuromuscular blocker by antagonizing calcium in the neuromuscular junction and myocardium
Blocks the release of catecholamines and has anticonvulsant properties
Often available in low-resource settings
Acts as a presynaptic neuromuscular blocker by antagonizing calcium in the neuromuscular junction and myocardium
Blocks the release of catecholamines and has anticonvulsant properties
Often available in low-resource settings
Metronidazole 500mg IV (7.5mg/kg) q6hrs OR
Clindamycin 600mg IV (7.5mg/kg) q6hrs
Although once the drug of choice it is now no longer recommended since it may potentiate the effect of<unk>  toxin by inhibiting the GABA receptors
Acute tetanus
Herpes zoster oticus
Akathisia
Crotaline envenomation
Conversion disorder
Herpes zoster
Drug toxicity 
Stonefish envenomation